We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Guidelines Seek to Speed Development of Antibacterial Drugs
FDA Guidelines Seek to Speed Development of Antibacterial Drugs
Drug companies can streamline the development of new antibacterial drugs for seriously ill patients by applying less rigorous standards of effectiveness and more limited clinical trials than typical, the FDA said in guidance issued Aug. 1.